跳至主要内容
临床试验/NL-OMON20942
NL-OMON20942已完成不适用

Prospective Assessment of Risk Factors for Appropriate ICD Intervention in Patients with Ischemic Cardiomyopathy.

BIOTRONIK SE & Co. KGWoermannkehre 1D - 12359 BerlinGermany0049 (0)30 689-0500 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patient with ischemic cardiomyopathy indicated for a de novo ICD implantation for primary prevention, according to ESC guidelines or local standards (MADIT II population);
  • 2. Written informed consent / willingness and ability to comply with the protocol.

排除标准

  • 1. Contraindication for MRI;
  • 2. Severe renal dysfunction (stage 4 or 5) resulting in contra-indication for the admission of gadolinium during MRI;

研究者

发起方
BIOTRONIK SE & Co. KGWoermannkehre 1D - 12359 BerlinGermany0049 (0)30 689-050

相似试验